The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

NCT05037825 · clinicaltrials.gov ↗

RECRUITING

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Carcinoma
Malignant Melanoma
Renal Cell Carcinoma
Triple-Negative Breast Cancer

Interventions

DRUG: Checkpoint Inhibitor, Immune

Sponsor

VastBiome